3 Results for "

A549 wild-type cells

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "A549 wild-type cells" in MCE Product Catalog:

Cat. No.: HY-174245
CAS No.: 3081389-07-0
Target:  

RET

Research Areas:  

Cancer

RET-IN-30 (Compound 28) is a RET inhibitor that exhibits inhibitory activity against both wild-type RET and some of its mutants. RET-IN-30 can inhibit the proliferation of A549 cells and has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-175354
Target:  

PROTACs E1/E2/E3 Enzyme

Research Areas:  

Others

PROTAC BET Degrader-13 is a BET PROTAC degrader that recruits TRIM21. PROTAC BET Degrader-13 utilizes wild-type TRIM21 to mediate the degradation of PML-eGFP-BRD4 (BD2) fusion protein aggregates, with an EC50 of 1.4 μM in A549 cells expressing TRIM21-FLAG. PROTAC BET Degrader-13 can be used for research on targeted protein degradation and protein aggregate clearance .
loading...
    loading...
Cat. No.: HY-170438
CAS No.: 1574321-31-5
Target:  

EGFR

Research Areas:  

Cancer

EGFR-IN-139 (compound PD 18) is an epidermal growth factor receptor (EGFR) inhibitor, with IC50s of 12.88 (wild type), 10.84 (L858R/T790M), 42.68 (L858R/T790M/C797S) nM, respectively. EGFR-IN-139 displays strong anticancer activity against A549 and H1975 cancer cell lines, which are highly expressed EGFR. EGFR-IN-139 has a strong selectivity to cancer cells. EGFR-IN-139 can be used for nonsmall cell lung cancer (NSCLC) research[1].
loading...
    loading...